Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» colorectal cancer
colorectal cancer
FDA Pushes Back PDUFA Dates for Amgen and Intercept
BioSpace
Fri, 10/18/24 - 11:28 am
FDA
Amgen
Lumakras
colorectal cancer
Intercept Pharma
Ocaliva
primary biliary cholangitis
Turnstone lays off 60% of staff, shakes up C-suite to keep cancer cell therapy on track
Fierce Biotech
Fri, 10/11/24 - 11:07 am
Turnstone Biologics
layoffs
colorectal cancer
head and neck cancer
uveal melanoma
Cash-strapped Gritstone starts search for strategic alternatives as cancer vaccine data underwhelm
Fierce Biotech
Tue, 10/1/24 - 10:48 am
Gritstone Bio
colorectal cancer
ESMO: Innovent links cytokine fusion protein to responses in colorectal cancer
Fierce Biotech
Wed, 09/18/24 - 01:38 pm
Innovent Biologics
cytokine fusion protein
colorectal cancer
clinical trials
ESMO: J&J cues up phase 3 for Rybrevant in colorectal cancer
Pharmaphorum
Mon, 09/16/24 - 09:45 am
ESMO
JNJ
Rybrevant
colorectal cancer
A Consumerized Diagnostic: Looking Back And Ahead On A Decade Of Cologuard
Forbes
Thu, 08/15/24 - 11:31 am
Cologuard
Medtech
diagnostics
colorectal cancer
FDA approves Guardant Health's blood-based cancer test
Reuters
Mon, 07/29/24 - 10:41 am
FDA
diagnostics
Guardant Health
colorectal cancer
Shield
Medtech
BMS gets FDA approval for Krazati in colorectal cancer
Pharmaphorum
Mon, 06/24/24 - 10:50 am
Bristol Myers Squibb
FDA
Krazati
colorectal cancer
Why 23andMe Stock Tumbled 10% on Tuesday
Motley Fool
Tue, 06/4/24 - 11:35 pm
23andMe
diagnostics
colorectal cancer
FDA advisers back approval for Guardant's blood-based cancer test
Reuters
Thu, 05/23/24 - 09:40 pm
Medtech
Guardant Health
FDA
colorectal cancer
diagnostics
FDA staff says Guardant's test may fail to detect some pre-cancerous tumors
Reuters
Tue, 05/21/24 - 11:12 am
diagnostics
Medtech
Guardant Health
colorectal cancer
FDA
A Takeda Oncology Leader’s Passion Fuels A Patient-First Approach
BioSpace
Tue, 04/30/24 - 09:10 am
Takeda
oncology
colorectal cancer
Fruzaqla
Annette Montandon
Exact Sciences, Guardant rally after Freenome colorectal cancer test results
Tip Ranks
Wed, 04/3/24 - 11:19 am
Medtech
diagnostics
Freenome
EXACT Sciences
Guardant Health
colorectal cancer
liquid biopsy
Gritstone shares fall on shaky study results for colorectal cancer vaccine
BioPharma Dive
Tue, 04/2/24 - 11:36 am
Gritstone Bio
colorectal cancer
clinical trials
cancer vaccines
A simple blood test can detect colorectal cancer early, study finds
NPR
Thu, 03/14/24 - 11:20 am
Guardant Health
diagnostics
Medtech
colorectal cancer
clinical trials
Bristol Myers shows power of Opdivo-Yervoy combo in first-line colorectal cancer subset
Fierce Pharma
Sun, 01/21/24 - 05:09 pm
Bristol Myers Squibb
colorectal cancer
Opdivo-Yervoy
AbbVie-backed Disco gets down with €20M to find new targets for antibody-based therapies
Fierce Biotech
Tue, 01/16/24 - 09:14 am
Disco Pharmaceuticals
AbbVie
venture capital
lung cancer
colorectal cancer
Merck KGaA bets on Inspirna’s colorectal cancer drug ompenaclid
Pharmaphorum
Thu, 01/4/24 - 10:09 am
Merck KGaA
Inspirna
colorectal cancer
ompenaclid
Takeda’s Fruzaqla (Fruquintinib) Gets FDA Nod for Metastatic Colorectal Cancer
Xtalks
Thu, 12/21/23 - 09:42 am
Takeda
FDA
colorectal cancer
fruquintinib
Fruzaqla
BMS Builds Case for Opdivo, Yervoy Combo in First-Line Colorectal Cancer
BioSpace
Fri, 12/8/23 - 10:00 am
Bristol Myers Squibb
Opdivo
Yervoy
colorectal cancer
metastatic colorectal cancer
clinical trials
Pages
1
2
3
4
5
6
7
8
9
next ›
last »